Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation and use of protein kinase inhibitors

A kind of use, leukemia technology, applied in the direction of medical preparations containing active ingredients, drug combinations, organic chemistry, etc.

Active Publication Date: 2021-01-05
RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE +2
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, resistance to kinase-directed therapy can develop

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation and use of protein kinase inhibitors
  • Preparation and use of protein kinase inhibitors
  • Preparation and use of protein kinase inhibitors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0217] Example 1: General Reaction Sequence for Compounds of Formula IA

[0218] Compounds of formula IA were synthesized according to Scheme 1 . Exemplary methods are also described below.

[0219] Scheme 1: General reaction sequence for compounds of formula IA

[0220]

Embodiment 2

[0221] Embodiment 2: the synthesis of compound 2

[0222]

[0223] ethyl-4-(methylamino)-2-(methylthio)pyrimidine-5-carboxylate. To a stirred solution of 500 mL of compound 1 (40 g, 172 mmol) in DCM was slowly added 70 mL of 23% methylamine in ethanol at 0°C. The resulting mixture was stirred at 0°C for 45 minutes. After compound 1 was completely consumed according to TLC monitoring, 300 mL of water was added to the mixture. The organic layer was separated and washed with brine (2 x 200 mL), dried over anhydrous magnesium sulfate, filtered and evaporated to give 36.86 g of the desired product as a white solid. Yield: 94%.

Embodiment 3

[0224] Embodiment 3: the synthesis of compound 3

[0225]

[0226] (4-(methylamino)-2-(methylthio)pyrimidin-5-yl)methanol. at 0°C, in N 2A THF solution (200 mL) of compound 2 (36.86 g, 162.2 mmol) was added to a THF (dry, 800 mL) suspension of LAH (7.38 g, 194.6 mmol) through the dropping funnel. The mixture was stirred at room temperature for 2 hours. TLC indicated complete consumption of compound 2. Water (8 mL), 15% NaOH solution (24 mL) and water (24 mL) were added to the reaction mixture. The organic layer was decanted and the solid was washed with EA (2 x 50 mL). All organic layers were combined and washed with brine (100 mL), MgSO 4 Dry, filter and evaporate under reduced pressure. The resulting yellow solid (27 g) was recrystallized from EA / PE (1 / 1) to give 18.5 g of the desired product in the form of a white solid. Yield: 62%. 1 H NMR, 500MHz (CDCl 3 ), 7.68 (s, 1H), 5.87 (bs, 1H), 4.50 (s, 1H), 3.04 (d, 3H, J=5.0Hz), 2.52 (s, 3H), 1.67 (b, 3H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides novel compounds and methods of using such compounds to treat or prevent cancer.

Description

Background technique [0001] Protein kinases represent a large class of proteins that play a central role in regulating a variety of cellular processes and maintaining control over cellular functions. Kinases are associated with a variety of cancers and thus represent an attractive class of therapeutic targets. However, resistance to kinase-directed therapy can develop. Contents of the invention [0002] Additionally, the present invention provides specific compounds (and compositions thereof) and demonstrates their effectiveness, eg, as inhibitors of one or more protein kinases. In some embodiments, provided compounds and / or compositions can be used in medicine. In some embodiments, provided compounds and / or compositions are used for the treatment (e.g., therapeutic and / or prophylactic treatment) of one or more kinase-associated diseases, disorders, or conditions (e.g., associated with one or Diseases, disorders or conditions associated with the level and / or activity of m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D487/04A61K31/519A61K31/5377A61K31/551A61P35/00A61P35/02
CPCA61P35/00A61P35/02C07D487/04
Inventor 任瑞宝邓贤明刘萍焦波黄伟
Owner RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE